CCL2 (monocyte chemoattractant protein-1) and cancer

Seminars in Cancer Biology
Ilaria Conti, Barrett J Rollins

Abstract

Genetic analyses of cancer in humans indicate that chemokines and their receptors are unlikely to play direct roles in pathogenesis. However, these molecules have pleiotropic effects that impact on cancer pathobiology in animal models, and there is evidence that they may do the same in humans. Given their protean properties, chemokines could have tumor-promoting, tumor-suppressing activities, or either depending on context. An example is found in CCL2, a chemokine that attracts and activates mononuclear cells. In some settings, it stimulates host anti-tumor activities. However, tumor cells themselves secrete CCL2 suggesting that it has growth promoting effects. These have been documented in animal models and clinical epidemiological studies. If CCL2's protumorigenic activities can be validated, then CCL2 and its receptor CCR2 may be therapeutic targets in cancer.

References

Jul 1, 1992·Immunology Today·A MantovaniL Ruco
Sep 30, 1991·International Journal of Cancer. Journal International Du Cancer·S WalterA Mantovani
Jun 1, 1991·Molecular and Cellular Biology·B J Rollins, M E Sunday
Jun 1, 1990·The Journal of Experimental Medicine·C O ZachariaeK Matsushima
Apr 10, 1997·International Journal of Cancer. Journal International Du Cancer·S J YoungsR C Rees
Oct 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·W A KuzielN Maeda
Dec 31, 1997·The Journal of Experimental Medicine·T KuriharaR Bravo
Mar 17, 1999·The Journal of Clinical Investigation·J GoslingI F Charo
Jun 11, 1999·Biochemical and Biophysical Research Communications·B H RovinR Saxena
Jul 27, 1999·International Journal of Cancer. Journal International Du Cancer·V GoedeH G Augustin
Jul 27, 1999·Gastroenterology·M B DwinellM F Kagnoff
Oct 25, 2002·International Journal of Cancer. Journal International Du Cancer·Masahiro OhtaKazuaki Chayama
Dec 20, 2002·Nature·Peter Libby

❮ Previous
Next ❯

Citations

May 7, 2014·Biochemical and Biophysical Research Communications·Fang Yan, Qiang Fu
Jul 22, 2014·Frontiers in Biology·Wei Bin FangNikki Cheng
Jul 4, 2007·The Journal of Clinical Investigation·Robert J B NibbsGerard J Graham
Dec 23, 2008·BMC Cancer·Pablo Sáenz-LópezFrancisco Ruiz-Cabello
May 16, 2009·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Satish L DeshmaneBassel E Sawaya
Dec 8, 2009·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Kenneth Wilfried KrossHans Jørgen Aarstad
Dec 24, 2009·Cancer Research·Zvi G FridlenderSteven M Albelda
Apr 17, 2010·American Journal of Respiratory Cell and Molecular Biology·Zvi G FridlenderSteven M Albelda
Jul 30, 2010·Neuro-oncology·Adam WuAmy B Heimberger
Sep 22, 2010·Proceedings of the National Academy of Sciences of the United States of America·Christophe E RedonOlga A Sedelnikova
Oct 12, 2010·Proceedings of the National Academy of Sciences of the United States of America·Jiri BartekJirina Bartkova
Dec 8, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tong SunPhilip W Kantoff
May 12, 2011·Cancer Research·Olga A MartinWilliam M Bonner
May 23, 2012·Oncogene·M K HerroonI Podgorski
Mar 6, 2012·Protein Engineering, Design & Selection : PEDS·India C SeverinAmanda E I Proudfoot
Dec 23, 2011·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Adit Ben-Baruch
Sep 25, 2007·Clinical & Experimental Metastasis·Adit Ben-Baruch
Nov 13, 2008·Clinical & Experimental Metastasis·Yi LuJian Zhang
Aug 17, 2005·American Journal of Clinical Pathology·Massimo LocatiMassimiliano M Corsi
Oct 4, 2006·Cancer Metastasis Reviews·A Ben-Baruch
Jan 21, 2011·Cancer Metastasis Reviews·Trina J Stewart, Mark J Smyth
Feb 13, 2007·Annual Review of Immunology·Samantha J AllenTracy M Handel
Aug 24, 2010·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Bedia AgachanTurgay Isbir
Jan 31, 2008·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Mengchang WangPengbo Liu
Apr 17, 2016·The Journal of Surgical Research·Fumiho SanoKimikazu Hamano
Feb 26, 2013·Leukemia & Lymphoma·Fotis AsimakopoulosPeiman Hematti
Nov 26, 2010·Scandinavian Journal of Gastroenterology·Andrew J GawronLifang Hou
Sep 24, 2014·Neoplasia : an International Journal for Oncology Research·Yaeli Lebel-HazivAdit Ben-Baruch
Apr 26, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Hongxia MaHongbing Shen
Dec 17, 2009·Cytokine & Growth Factor Reviews·Alberto MantovaniRaffaella Bonecchi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Carcinosarcoma

Carcinosarcoma is a malignant neoplasm that contains elements of carcinoma and sarcoma so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue. Discover the latest research on carcinosarcoma here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.